Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on LinkedIn:
“New Issue Alert: EHJ Cardiovascular Pharmacotherapy (September 2026)
This issue explores the transition from universal evidence to personalised cardiovascular pharmacotherapy, spanning trial heterogeneity, precision anticoagulation, medication adherence, drug safety, and complex pharmacokinetic challenges across diverse patient populations.
Highlights include an editorial on contextual pharmacotherapy, thought provoking discussions on inconsistency across pharmacological trials, new perspectives on extended anticoagulation for cancer associated thrombosis, machine learning approaches to statin adherence, a comprehensive review of hydroxychloroquine cardiotoxicity, and an in depth analysis of pharmacokinetics in Fontan circulation.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery